Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 5OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 17Leukemia, Myeloid, Acute 16Breast Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Non-Hodgkin 11Carcinoma, Non-Small-Cell Lung 11Lymphoma, Mantle-Cell 10Leukemia 10Lymphoma, Follicular 9Hodgkin Disease 9Myelodysplastic Syndromes 8Recurrence 7Neuroblastoma 7Neoplasm Metastasis 7Leukemia, Lymphocytic, Chronic, B-Cell 7Brain Neoplasms 7Neoplasms, Plasma Cell 6Lymphoma, B-Cell, Marginal Zone 6Lung Neoplasms 6Glioblastoma 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, T-Cell 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell 5Immunoblastic Lymphadenopathy 5Burkitt Lymphoma 5

Interventions

Irinotecan 16Paclitaxel 14Docetaxel 13Gemcitabine 12Cisplatin 12Capecitabine 8Oxaliplatin 7Temozolomide 6Leucovorin 6Fluorouracil 6Carboplatin 6Topotecan 5Chromatography, High Pressure Liquid 5Polymerase Chain Reaction 4Pharmacogenomic Testing 4Pemetrexed 4Immunohistochemistry 4Filgrastim 4Everolimus 4Etoposide 4Early Intervention, Educational 4Celecoxib 4tipifarnib 3ixabepilone 3bryostatin 1 3Tegafur 3Sorafenib 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Lapatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unspecified Adult Solid Tumor, Protocol Specific × Vorinostat × Clear all
NCT00121277 2015-07-23

Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

University Health Network, Toronto

Phase 1 Completed
28 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡